Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Warfarin in Unexplained Oligohydramnios
NCT01569035Phase 4Terminated
- Sponsor
- Woman's Health University Hospital
- Start
- Jan 2009
- Primary completion
- Jul 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of warfarin in Oligohydramnios (Oligo), sponsored by Woman's Health University Hospital. Started Jan 2009; status: terminated.
02
Drugs
warfarin
03
Conditions
Oligohydramnios (Oligo)
Beyond the preview
Go deeper on NCT01569035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01569035.